Developer of cancer therapeutics designed to treat cancer. InxMed is based in Nanjing, China. Its last reported valuation was $306 million in Aug 2025. It has raised $132 million.
Last reported valuation
$306.0M
Oct 2026
Priced at
—
Total raised
$131.6M
Last round
—
Team — not yet on record
No current team members for InxMed are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of InxMed with a free account
·The complete investor list: 11 names
·Watch InxMed: the Monday email on marks, rounds and moves
